ADHD has recently been noticed among patients in Korea. It is one of the diseases that is increasing noticeably. According to the National Health Insurance Corporation, last 2021In Korea ADHD The number of patients treated 10only 2322people were surveyed. This is 2017Compared to the previous year, this figure increased by 92.9%, showing a slight annual increase The number of people receiving treatment has increased overwhelmingly since 2020< span style="font-weight:bold;">. Especially ADHD appears frequently in childhood, and as of 2021, 10hits 6People 10It was found to be less than ..

ADHDis distraction, Hyperactivity, It affects daily life with symptoms such as impulsivity, but it is not genetic, Neurological, social-psychological factors It is difficult to find the exact cause because it is mixed. For this reason, even if patients are diagnosed early, they need to undergo treatment for several years, and since symptoms often persist into adulthood, they suffer from psychological , There is no choice but to suffer economically.

In order to relieve the suffering of these patients, Emotiv provides wellness services that provide proper pre-diagnosis screening and treatment during childhood, the golden time for ADHD. We are developing services and digital treatment devices. It is noteworthy that games are incorporated into treatment to encourage children's active participation and immersion. We met with Min Sang-sang, CEO of Emotive, who is drawing a bright future for ADHD treatment through research collaborations with various hospitals, to learn more. I heard it.

Please introduce your company

Emotive uses its unique technologies of cognitive modeling, artificial intelligence, and mobile games to educate children. ADHD, autism, for adults ADHD It is a company that researches and develops digital treatment devices and healthcare technologies. As a startup that has been established 3 years, 32 multidisciplinary students Talented people are gathering and working hard to research with the goal of making treatment and care enjoyable' .

We plan to conduct confirmatory clinical trials with Seoul National University Hospital and Hanyang University Hospital in December this year. and Seoul St. Mary's Hospital, Busan Paik Hospital, Soonchunhyang Seoul Hospital, We are conducting research collaboration with Yonsei Severance Hospital and others. Also this year, CES Innovation Award and the world's 3rd largest design award, Red Dot< /span>(Red dot) Emotiv’s innovation and technical capabilities were proven by winning a design award.

It is difficult to determine the exact cause of ADHD, but it is often due to genetics and most cases appear in childhood. So, since the golden time for treatment is during childhood, I started a business to help people diagnose and start treatment quickly..

Please tell us about your main business

Our main field is Children's ADHD, which won the CES2023 Innovation Award and the Red Dot Design Award. >It is a wellness service for. Main features include screening for ADHDand cognitive enhancement content. Children with ADHD generally have poor cognitive abilities. So, it is necessary to measure cognitive ability and continuously strengthen it, but existing cognitive ability enhancement programs cannot be continued for a long time because children do not find it fun. Also ADHD children have poor social skills, so they spend a lot of time alone, so most of them like games. Considering these aspects, the company chose the game method. We used games that children like to increase immersion and make treatment fun for a long time.

Measurement of our 'cognitive ability/ADHD potential ' The solution was created based on various diagnostic aids used in actual hospitals, and all of our results are based on medical and clinical grounds. It was researched and developed based on Measurement can be done in as little as 30 minutes, and the accuracy of the ADHD screening possibility measurement is 96% < span>about. Currently, Seoul National University Hospital, is conducting experiments for basic data with the help of Busan Paik Hospital and is continuously adding content to ensure high compliance. Trying to maintain it. In addition, based on clinical data,We are also developing therapeutic device technology aiming for approval by the Ministry of Food and Drug Safety, and will undergo clinical trials in December of this year and 2024 >Aiming for approval from the Ministry of Food and Drug Safety within the year.

What are your future goals

The company will operate from December of this year until 2024 We plan to successfully conduct clinical trials for ADHD and autism(ASD) and achieve approval from the Ministry of Food and Drug Safety in one breath. Currently, the digital therapy device(DTx) approved in Korea only has a solution for insomnia ADHD >Emotive wants to grow rapidly at home and abroad with its first title. In the future, we will expand our technology and services to include adult ADHD and depression, providing more services to make treatment and care enjoyable. I want to establish myself as a company.

Because it is still an early market, there are a lot of things to prove and a lot to achieve about the technology and market. Emotiv will bring about innovation in the domestic and international markets through the game method and unique technology called cognitive modeling..